Skip to main content

Table 5 Additional analysis by mixed effects modelsa of changes in outcome variables adjusted for plasma levels of markers of inflammation and bicarbonate and residual renal function

From: Supervised oral protein supplementation during dialysis in patients with elevated C-reactive protein levels: a two phase, longitudinal, single center, open labeled study

 

Δ interventional phasea (95 % CI), p values

PNA (g/kg/day)

0.17 (0.05, 0.29),p = 0.005

MAMC (cm)

0.50 (−0.39, 1.40),p = 0.262

Plasma albumin (g/dL)

−0.04 (−0.14, 0.05),p = 0.368

BMI (kg/m2)

−0.19 (−0.53, 0.16),p = 0.282

SF12- PCS

−2.91 (−6.86, 1.04),p = 0.145

SF12- MCS

1.18 (−1.77, 4.12),p = 0.426

  1. aAdjusted for the change in interventional phase in plasma hsCRP, TNFα, IL6 and bicarbonate and residual renal function